Quercis Announces Executive Leadership Appointments
Proven life science entrepreneurs from COMPASS Pathways appointed to key operational roles
News provided by
Share this article
Share this article
ZUG, Switzerland, April 13, 2021 /PRNewswire/ Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announces the appointment of several new executives to the Company s leadership team. John Boghossian, former Vice President of Operations at COMPASS Pathways, will join Quercis as Chief Executive Officer; Manon Veraart, former Vice President of Business Development at COMPASS Pathways, will join as Chief Business Officer. In addition, Thomas Pfeiffer, Ph.D., former Senior Researcher at University College London, will join as Director of Pipeline Projects. Ilias Läber, Ph.D., the current Chief Executive Officer at Quercis, will transition out of his operational role by end of April 2021 and will remain in his